FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316171385> ?p ?o ?g. }

• W4316171385 endingPage "312" @default.
• W4316171385 startingPage "301" @default.
• W4316171385 abstract "Seroprevalence studies can be used to measure the progression of national COVID-19 epidemics. The Danish National Seroprevalence Survey of SARS-CoV-2 infections (DSS) was conducted as five separate surveys between May 2020 and May 2021. Here, we present results from the two last surveys conducted in February and May 2021.Persons aged 12 or older were randomly selected from the Danish Population Register and those having received COVID-19 vaccination subsequently excluded. Invitations to have blood drawn in local test centers were sent by mail. Samples were analyzed for whole Immunoglobulin by ELISA. Seroprevalence was estimated by sex, age and geography. Comparisons to vaccination uptake and RT-PCR test results were made.In February 2021, we found detectable antibodies in 7.2% (95% CI: 6.3-7.9%) of the invited participants (participation rate 25%) and in May 2021 in 8.6% (95% CI: 7.6-9.5%) of the invited (participation rate: 14%). Seroprevalence did not differ by sex, but by age group, generally being higher among the <50 than 50+ year-olds. In May 2021, levels of seroprevalence varied from an estimated 13% (95% CI: 12-15%) in the capital to 5.2% (95% CI: 3.4-7.4%) in rural areas. Combining seroprevalence results with vaccine coverage, estimates of protection against infection in May 2021 varied from 95% among 65+ year-olds down to 10-20% among 12-40 year-olds. In March-May 2021, an estimated 80% of all community SARS-CoV-2 infections were diagnosed by RT-PCR and captured by surveillance.Seroprevalence estimates doubled during the 2020-21 winter wave of SARS-CoV-2 infections and then stabilized as vaccinations were rolled out. The epidemic affected large cities and younger people the most. Denmark saw comparatively low infections rates, but high test coverage; an estimated four out of five infections were detected by RT-PCR in March-May 2021." @default.
• W4316171385 created "2023-01-15" @default.
• W4316171385 creator A5005779461 @default.
• W4316171385 creator A5014786621 @default.
• W4316171385 creator A5016974789 @default.
• W4316171385 creator A5017235649 @default.
• W4316171385 creator A5032069062 @default.
• W4316171385 creator A5035345936 @default.
• W4316171385 creator A5073573220 @default.
• W4316171385 creator A5074902538 @default.
• W4316171385 creator A5078808443 @default.
• W4316171385 creator A5084976988 @default.
• W4316171385 creator A5090564143 @default.
• W4316171385 date "2023-01-01" @default.
• W4316171385 modified "2023-10-18" @default.
• W4316171385 title "Seroprevalence of SARS-CoV-2 Antibodies in Denmark: Results of Two Nationwide Population-Based Surveys, February and May 2021" @default.
• W4316171385 cites W11414727 @default.
• W4316171385 cites W1978670003 @default.
• W4316171385 cites W2002275887 @default.
• W4316171385 cites W2888669266 @default.
• W4316171385 cites W3046855964 @default.
• W4316171385 cites W3093877663 @default.
• W4316171385 cites W3128017291 @default.
• W4316171385 cites W3136789838 @default.
• W4316171385 cites W3137307037 @default.
• W4316171385 cites W3148157927 @default.
• W4316171385 cites W3158005252 @default.
• W4316171385 cites W3173470851 @default.
• W4316171385 cites W3194807182 @default.
• W4316171385 cites W3197430550 @default.
• W4316171385 cites W3201697469 @default.
• W4316171385 cites W3209344412 @default.
• W4316171385 cites W3212171701 @default.
• W4316171385 cites W3213235777 @default.
• W4316171385 cites W3214607193 @default.
• W4316171385 cites W4200184323 @default.
• W4316171385 cites W4200401272 @default.
• W4316171385 cites W4214662176 @default.
• W4316171385 cites W4225125921 @default.
• W4316171385 cites W4225518587 @default.
• W4316171385 cites W4226050536 @default.
• W4316171385 cites W4226504672 @default.
• W4316171385 cites W4281627142 @default.
• W4316171385 cites W4283719322 @default.
• W4316171385 cites W4292774342 @default.
• W4316171385 cites W4308706077 @default.
• W4316171385 cites W4309135076 @default.
• W4316171385 doi "https://doi.org/10.2147/idr.s383491" @default.
• W4316171385 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36683911" @default.
• W4316171385 hasPublicationYear "2023" @default.
• W4316171385 type Work @default.
• W4316171385 citedByCount "1" @default.
• W4316171385 countsByYear W43161713852023 @default.
• W4316171385 crossrefType "journal-article" @default.
• W4316171385 hasAuthorship W4316171385A5005779461 @default.
• W4316171385 hasAuthorship W4316171385A5014786621 @default.
• W4316171385 hasAuthorship W4316171385A5016974789 @default.
• W4316171385 hasAuthorship W4316171385A5017235649 @default.
• W4316171385 hasAuthorship W4316171385A5032069062 @default.
• W4316171385 hasAuthorship W4316171385A5035345936 @default.
• W4316171385 hasAuthorship W4316171385A5073573220 @default.
• W4316171385 hasAuthorship W4316171385A5074902538 @default.
• W4316171385 hasAuthorship W4316171385A5078808443 @default.
• W4316171385 hasAuthorship W4316171385A5084976988 @default.
• W4316171385 hasAuthorship W4316171385A5090564143 @default.
• W4316171385 hasBestOaLocation W43161713851 @default.
• W4316171385 hasConcept C106192422 @default.
• W4316171385 hasConcept C126322002 @default.
• W4316171385 hasConcept C138885662 @default.
• W4316171385 hasConcept C144024400 @default.
• W4316171385 hasConcept C149923435 @default.
• W4316171385 hasConcept C159654299 @default.
• W4316171385 hasConcept C164622146 @default.
• W4316171385 hasConcept C203014093 @default.
• W4316171385 hasConcept C22070199 @default.
• W4316171385 hasConcept C2778494684 @default.
• W4316171385 hasConcept C2779134260 @default.
• W4316171385 hasConcept C2908647359 @default.
• W4316171385 hasConcept C3007834351 @default.
• W4316171385 hasConcept C3008058167 @default.
• W4316171385 hasConcept C41895202 @default.
• W4316171385 hasConcept C45189115 @default.
• W4316171385 hasConcept C524204448 @default.
• W4316171385 hasConcept C71924100 @default.
• W4316171385 hasConcept C99454951 @default.
• W4316171385 hasConceptScore W4316171385C106192422 @default.
• W4316171385 hasConceptScore W4316171385C126322002 @default.
• W4316171385 hasConceptScore W4316171385C138885662 @default.
• W4316171385 hasConceptScore W4316171385C144024400 @default.
• W4316171385 hasConceptScore W4316171385C149923435 @default.
• W4316171385 hasConceptScore W4316171385C159654299 @default.
• W4316171385 hasConceptScore W4316171385C164622146 @default.
• W4316171385 hasConceptScore W4316171385C203014093 @default.
• W4316171385 hasConceptScore W4316171385C22070199 @default.
• W4316171385 hasConceptScore W4316171385C2778494684 @default.
• W4316171385 hasConceptScore W4316171385C2779134260 @default.
• W4316171385 hasConceptScore W4316171385C2908647359 @default.
• W4316171385 hasConceptScore W4316171385C3007834351 @default.

• next